Also known as: hypertransfusion therapy.
What is hypertransfusion management?
Hypertransfusion management is a form of blood transfusion that’s aimed at reducing the risk of complications such as stroke in patients with sickle cell disease.
What happens during the procedure?
For patients with a history of a stroke, hypertransfusion management is a simple transfusion to raise the hemoglobin concentration to approximately 10 g/dL. It reduces complications of sickle cell by using intermittent, long-term transfusions to dilute the blood. As with most blood transfusions, the blood is injected into the body via IV.
Is any special preparation needed?
Hypertransfusion management is a special procedure that’s only right for certain patients. Testing may be required to determine if it’s the proper treatment. Blood testing is required to determine the patient’s blood type. This way, compatible blood can be used for the transfusion.
What are the risk factors?
Infection, bleeding, bruising, shortness of breath and chest or back pain are potential risks of hypertransfusion management.
Reviewed by: Athena C Pefkarou, MD
This page was last updated on: 11/26/2018 10:51:10 AM
From the Newsdesk
Oscar, 20, was born with Sickle Cell Disease, a condition that affects red blood cells (sickle cell anemia) and blockage of blood flow causing pain. The pain is often so severe; patients suffer painful bouts known as sickle cell crisis and often require hospitalization.
Children with SCD may present anemia, repeated infections, and shortness of breath.